Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Privia Health GroupPRVA -1.08%88 EV-to-EBITDA is 55.53 as of Jul. 30, 2026, which is 29% below its 10-year median of 77.94. GuruFocus rates PRVA with a GF Score™ of 88/100 and a GF Value™ of $27.58 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Privia Health Group ranks worse than 92.53% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Privia Health Group's enterprise value is $2,650 Mil.
Privia Health Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $48 Mil. Therefore, Privia Health Group's EV-to-EBITDA for today is 55.53.
The historical rank and industry rank for Privia Health Group's EV-to-EBITDA or its related term are showing as below:
PRVA'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -203.97 Med: 77.94 Max: 854.41
Current: 55.53
During the past 8 years, the highest EV-to-EBITDA of Privia Health Group was 854.41. The lowest was -203.97. And the median was 77.94.
PRVA's EV-to-EBITDA is ranked worse than 92.53% of 509
companies
in the Healthcare Providers & Services industry
Industry Median: 11.01
vs PRVA: 55.53
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Privia Health Group (NAS:PRVA) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Privia Health Group's PE Ratio (TTM) for today is calculated as:
Privia Health Group's share price for today is $23.87.
Privia Health Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.160.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Privia Health Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Privia Health Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Privia Health Group EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Privia Health Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Privia Health Group's EV-to-EBITDA falls into.
Privia Health Group's current Enterprise Value is $2,650 Mil.
Privia Health Group's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $48 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Privia Health Group (PRVA) has a EV-to-EBITDA of 55.53 as of Jul. 30, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Privia Health Group. This is 29% below median its historical median of 77.94. According to the industry distribution chart, Privia Health Group ranks #471 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 92.5%.
Is Privia Health Group's EV-to-EBITDA too high?
Privia Health Group's current EV-to-EBITDA of 55.53 is 29% below median its 10-year median of 77.94. The Healthcare Providers & Services industry median EV-to-EBITDA is 11.01. Privia Health Group's value of 55.53 is 404.4% above this industry median. Based on the distribution chart, Privia Health Group ranks #471 out of 509 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Privia Health Group has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Privia Health Group's EV-to-EBITDA compare to DOCS and WAY?
According to the Healthcare Providers & Services industry distribution chart, Privia Health Group ranks #471 out of 509 companies for EV-to-EBITDA. This places Privia Health Group in the lower half of its industry. The industry median EV-to-EBITDA is 11.01. Privia Health Group's value of 55.53 is 404.4% above this benchmark. While the company's 10-year median is 77.94 vs. the industry median of 11.01, Privia Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 11.01, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Privia Health Group's current EV-to-EBITDA of 55.53 is 404.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Privia Health Group. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 11.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Privia Health Group's current EV-to-EBITDA is 55.53, which is 29% below median its own 10-year median of 77.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Privia Health Group stock overvalued right now?
Based on GuruFocus' analysis, Privia Health Group (PRVA) is currently considered Modestly Undervalued. The stock's GF Value™ is $27.58, compared to a current price of $23.87 — trading 13.5% below its estimated fair value. The current EV-to-EBITDA is 55.53, which is 29% below median its 10-year median of 77.94 and 404.4% above the Healthcare Providers & Services industry median of 11.01. Privia Health Group's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Privia Health Group (PRVA), the current EV-to-EBITDA is 55.53 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Privia Health Group (PRVA) Overvalued in 2026?
Based on GuruFocus' analysis, Privia Health Group stock appears to be undervalued.
The current stock price of $23.87 is trading 13.5% below its estimated GF Value™ of $27.58.
GuruFocus considers Privia Health Group to be Modestly Undervalued.
Key valuation signals for PRVA:
EV-to-EBITDA: 55.53 (29% below median its 10-year median of 77.94)
GF Value™: $27.58 vs. price of $23.87 (13.5% below fair value)
Industry Position: 404.4% above the Healthcare Providers & Services median (#471 of 509)
No single metric tells the full story. See the PRVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Privia Health Group Inc is one of the physician enablement companies in the United States with a presence in around 24 states and the District of Columbia. The group builds scaled provider networks with primary-care centric medical groups, risk-bearing entities, a physician-led governance structure, and the Privia Platform comprising an extensive suite of technology and service solutions. It collaborates with medical groups, health plans, and health systems to optimize approximately 1,300+ physician practices, improve the patient experience for over 5.8+ million patients, and reward around 5,300+ physicians and practitioners for delivering high-value care.
88GF Score
Get the complete analysis for PRVA
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRVA has been successfully added to your 
